nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antiretroviral therapy and obesity risk: a weighty question
|
Manne-Goehler, Jennifer |
|
|
12 |
7 |
p. e464-e465 |
artikel |
2 |
Effects of antiretrovirals on major adverse cardiovascular events in the REPRIEVE trial: a longitudinal cohort analysis
|
Fichtenbaum, Carl J |
|
|
12 |
7 |
p. e496-e505 |
artikel |
3 |
Expanding PrEP treatment options with a potent anti-HIV antibody
|
Frattari, Giacomo Schmidt |
|
|
12 |
7 |
p. e465-e467 |
artikel |
4 |
How can Africa sustain its HIV response amid US aid cuts?
|
Mutale, Wilbroad |
|
|
12 |
7 |
p. e468-e470 |
artikel |
5 |
Magnitude and characteristics of unsuppressed HIV viral load in children and adolescents on antiretroviral therapy in sub-Saharan Africa: a systematic review and meta-analysis
|
Mukuku, Olivier |
|
|
12 |
7 |
p. e506-e521 |
artikel |
6 |
Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trial
|
Ryan, Pablo |
|
|
12 |
7 |
p. e473-e484 |
artikel |
7 |
Progress in elimination of vertical HIV transmission
|
The Lancet HIV, |
|
|
12 |
7 |
p. e463 |
artikel |
8 |
Safety and pharmacokinetics of N6LS, a broadly neutralising monoclonal antibody for HIV: a phase 1, open-label, dose-escalation study in healthy adults
|
Wu, Richard L |
|
|
12 |
7 |
p. e485-e495 |
artikel |
9 |
The future of HIV diagnostics: an exemplar in infectious diseases
|
Pant Pai, Nitika |
|
|
12 |
7 |
p. e522-e531 |
artikel |
10 |
The global HIV response at a crossroads: protecting gains and advancing sustainability amid funding disruptions
|
Matanje, Beatrice |
|
|
12 |
7 |
p. e532-e536 |
artikel |
11 |
Time to say farewell to abacavir?
|
Waters, Laura |
|
|
12 |
7 |
p. e467-e468 |
artikel |
12 |
Uzbekistan's progress in HIV care blighted by stigma
|
Holt, Ed |
|
|
12 |
7 |
p. e471-e472 |
artikel |